Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, and commercializing pharmaceutical products for rare diseases. The company offers INCRELEX, treatment for children who suffer from severe primary insulin-like growth factor 1 deficiency (SPIGFD); ALKINDI SPRINKLE, as a replacement therapy for Adrenocortical Insufficiency (AI) in children under 17 years of age, and accurate dosing for newborns and children with AI; GALZIN, as a maintenance treatment for patients with Wilson Disease who have been initially treated with a chelating agent; PKU GOLIKE, medical formula for the dietary management of phenylketonuria (PKU); Carglumic Acid, treatment of acute and chronic hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency; Betaine Anhydrous, for the treatment of homocystinuria; Nitisinone for the treatment of tyrosinemia type 1; and Amglidia for the treatment of neonatal diabetes mellitus products. It also develops ET-600 for the treatment of central diabetes insipidus; ET-700 for the treatment of treatment of Wilson disease; ET-800; Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals (($ETON)) has held its Q2 earnings call. Read on for the main highlights of the call. Eton Pharmaceuticals’ latest earnings ca...

Eton Pharmaceuticals Earnings Call Signals Profitable Surge

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ProKidney (PROK), Eton Pharmaceuticals (ETON) and ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ETON	$59.78	-4.61%	588.75K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ETON	$59.78	-4.6%	588.75K
3
4
5
6

ETON

Get Eton Pharmaceuticals, Inc. Data in Excel

Get Eton Pharmaceuticals, Inc. Data in Excel